ArticleOncoTargets and therapy2018

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer.

Donggen Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.